BuyIn appoints Michael Rubas as new CEO effective June 2026

Christian P. Illek Board member for Finance Deutsche Telekom AG
Christian P. Illek Board member for Finance - Deutsche Telekom AG
0Comments

BuyIn, a procurement alliance formed by Deutsche Telekom and Orange, has named Michael Rubas as its new Chief Executive Officer. Rubas will assume the position on June 1, 2026, succeeding Béatrice Felder, who is retiring after more than six years with the company.

The shareholders and staff at BuyIn expressed their appreciation for Felder’s leadership during her tenure. “The shareholders and the BuyIn teams warmly thank Béatrice Felder for her leadership and key contribution to the company’s growth and transformation enhancing its positioning as a value creating partner over the past six years,” according to the announcement.

As CEO, Rubas will focus on expanding BuyIn’s procurement value through increased scale, improved pricing strategies, and further digital transformation. The alliance currently unites over ten major operators worldwide, managing procurement expenditures exceeding 20 billion euros.

Rubas joined BuyIn in 2020 as CFO, CHRO, and General Secretary. During his time at the company, he has emphasized digitization efforts and promoted sustainable supplier relationships. Before joining BuyIn, Rubas held senior roles at Deutsche Telekom from 2016 to 2020 and T-Systems from 2005 to 2016.

Rubas holds a Master’s degree in Consulting and Coaching for Change from HEC Paris and Saïd Business School at the University of Oxford. He also earned a Master of Business and Public Administration from Universität Konstanz and the University of Bath.



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.